🇺🇸 FDA

Intelligence · Patent portfolio

Vertex Pharmaceuticals (Australia) Patents

Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) — grant dates, expiration, and drug cross-links.

Patents
991
Expiring ≤24m
63

Quick answer

Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months — use filters for patent-cliff planning.

Page 10 of 21

  1. US 8546414

    Ion channel modulators and methods of use

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8541453

    Modulators of ATP-binding cassette transporters

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8541445

    Pyrazolopyridines

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8541025

    Co-crystals and pharmaceutical formulations comprising the same

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8536136

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8536195

    Bicyclic derivatives as modulators of ion channels

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8529882

    Peptidomimetic protease inhibitors

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8530489

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8524767

    Modulators of ATP binding cassette transporters

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8524720

    Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8524910

    Pyridyl derivatives as CFTR modulators

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8524906

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8524902

    [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8518938

    c-MET protein kinase inhibitors

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8519137

    Heteroaryl amides useful as inhibitors of voltage-gated sodium channels

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8518953

    Aminopyrimidines useful as inhibitors of protein kinases

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8513414

    Processes and intermediates for producing azaindoles

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8513282

    Modulators of cystic fibrosis transmembrane conductance regulator

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8507534

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8507687

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8507524

    Modulators of ATP-binding cassette-transporters

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8501446

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8497295

    Spiroindoline modulators of muscarinic receptors

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8492397

    Aminopyridine derivatives having Aurora A selective inhibitory action

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8492546

    Co-crystals and pharmaceutical compositions comprising the same

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8492403

    Bicyclic derivatives as modulators of voltage gated ion channels

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8486989

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8481552

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8481538

    Heterocyclic inhibitors of c-Met and uses thereof

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8481578

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8481551

    Gyrase and topoisomerase IV inhibitors

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8481524

    c-MET protein kinase inhibitors

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8476442

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8476281

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

    Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8471029

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8471014

    Process of making gyrase and topoisomerase IV inhibitors

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8466288

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8461156

    Modulators of ATP-binding cassette transporters

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8461345

    Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8461149

    Compounds useful as protein kinase inhibitors

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8455507

    Aminopyrimidines useful as kinase inhibitors

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8455497

    Inhibitors of aspartyl protease

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8450489

    Azaindoles useful as inhibitors of janus kinases

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8440706

    Inhibitors of serine proteases

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8436014

    Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8431556

    C-21-keto lupane derivatives preparation and use thereof

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8431615

    Dose forms

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vertex Pharmaceuticals (Australia) have?

991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vertex Pharmaceuticals (Australia) patents expire?

63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.